medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2026-3-67-71medalphabet-4951Research ArticleСтатьиЛечебно-диагностическая стратегия при ведении больных с акне, с учетом коморбидностиA treatment and diagnostic strategy for managing patients with acne, considering comorbidityhttps://orcid.org/0000-0002-5044-5265КругловаЛ. С.KruglovaL. S.

Круглова Лариса Сергеевна, д.м.н., профессор, заведующая кафедрой дерматовенерологии и косметологии, ректор

Москва

Kruglova Larisa S., Dr Med Sci (habil.), professor, head of Dept of Dermatovenereology and Cosmetology, rector

Moscow 

kruglovals@mail.ruhttps://orcid.org/0000-0003-4920-5288ОльховскаяК. Б.OlkhovskayaK. B.

Ольховская Кира Брониславовна, к.м.н., доцент кафедры дерматовенерологии и косметологии

Москва

Olkhovskaya Kira B., PhD Med, associate professor at Dept of Dermatovenereology and Cosmetology

Moscow 

olhovskaya_kira@mail.ruБыкановА. С.BykanovA. S.

Быканов Александр Сергеевич, дерматолог, врач-косметолог, дерматовенеролог, детский дерматолог

Москва

Bykanov Alexander Sergeevich, dermatologist, cosmetologist, dermatovenerologist, pediatric dermatologist

Moscow 

ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской ФедерацииРоссияCentral State Medical Academy of the Administrative Department of the President of the Russian FederationRussian Federation20261404202603Дерматология (1)6771Copyright © Круглова Л.С., Ольховская К.Б., Быканов А.С., 20262026Круглова Л.С., Ольховская К.Б., Быканов А.С.Kruglova L.S., Olkhovskaya K.B., Bykanov A.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/4951

Акне – мультифакториальное заболевание, которое развивается в результате взаимодействия большого количества этиологических факторов. Основные звенья патофизиологии заболевания изучены достаточно хорошо, однако нередко врачи дерматовенерологи отмечают фармакорезистентность больных акне к традиционной проводимой терапии, что может быть обусловлено наличием коморбидной патологии и приемом лекарственных препаратов. В данной статье представлен систематизированный обзор наиболее частых сопутствующих заболеваний, обусловливающих спектр диагностического поиска и терапевтических возможностей при сочетанном течении акне.

Acne is a multifactorial disease that develops as a result of the interaction of numerous etiologic factors. The key pathophysiological factors of the disease are well understood; however, dermatovenerologists often note that acne patients are resistant to traditional therapy, which may be due to comorbid conditions and medications. This article presents a systematic review of the most common comorbidities, which determine the range of diagnostic tests and therapeutic options for the combined course of acne.

акнекоморбидностьдиагностикалечениеизотретиноинacnecomorbiditydiagnosistreatmentisotretinoinReferencesDréno B. What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol. 2017 Sep; 31 (5): 8–12. https://doi.org/10.1111/jdv.14374Dréno B. What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol. 2017 Sep; 31 (5): 8–12. https://doi.org/10.1111/jdv.14374Al-Taie A, Hussein AN, Younes AA, Kassas M, Bandzhiki N. Acne vulgaris: Scoping insights towards pharmacological management and patient care prospects. J Sci Soc. 2025; 52: 326–334.Al-Taie A, Hussein AN, Younes AA, Kassas M, Bandzhiki N. Acne vulgaris: Scoping insights towards pharmacological management and patient care prospects. J Sci Soc. 2025; 52: 326–334.Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024 May; 90 (5): 1006.e1–1006.e30. https://doi.org/10.1016/j.jaad.2023.12.017Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024 May; 90 (5): 1006.e1–1006.e30. https://doi.org/10.1016/j.jaad.2023.12.017Корсунская И.М., Невозинская З.А., Панюкова С.В., Соркина И.Л., Сюч Н.И. Терапия акне на фоне себорейного дерматита. Клиническая дерматология и венерология. 2010; 8 (2): 53–56.Korsunskaya I.M., Nevozinskaya Z.A., Panyukova S.V., Sorkina I.L., Syuch N.I. Acne therapy against the background of seborrheic dermatitis. Clinical dermatology and venereology. 2010; 8 (2): 53–56. (In Russ.).Полеско Н.В., Осипов Г.А., Кабаева Т.А. Микроэкология организма человека при себорее и акне. Детские инфекции. 2006; 5 (3): 26–33.Polesko N.V., Osipov G.A., Kabaeva T.A. Microecology of the human body in seborrhea and acne. Childhood infections. 2006; 5 (3): 26–33. (In Russ.).Kirsten N, Mohr N, Augustin M. Prevalence and cutaneous comorbidity of acne vulgaris in the working population. Clin Cosmet Investig Dermatol. 2021 Oct 2; 14: 1393–1400. https://doi.org/10.2147/CCID.S322876Kirsten N, Mohr N, Augustin M. Prevalence and cutaneous comorbidity of acne vulgaris in the working population. Clin Cosmet Investig Dermatol. 2021 Oct 2; 14: 1393–1400. https://doi.org/10.2147/CCID.S322876Wang MA, Wilson A, Murrell DF. A review of the scoring and assessment of keratosis pilaris. Skin Appendage Disord. 2023 Aug; 9 (4): 241–251. https://doi.org/10.1159/000529487Wang MA, Wilson A, Murrell DF. A review of the scoring and assessment of keratosis pilaris. Skin Appendage Disord. 2023 Aug; 9 (4): 241–251. https://doi.org/10.1159/000529487Moran EM, Foley R, Powell FC. Demodex and rosacea revisited. Clin Dermatol. 2017 Mar-Apr; 35 (2): 195–200. https://doi.org/10.1016/j.clindermatol.2016.10.014Moran EM, Foley R, Powell FC. Demodex and rosacea revisited. Clin Dermatol. 2017 Mar-Apr; 35 (2): 195–200. https://doi.org/10.1016/j.clindermatol.2016.10.014Aktaş Karabay E, Aksu Çerman A. Demodex folliculorum infestations in common facial dermatoses: Acne vulgaris, rosacea, seborrheic dermatitis. An Bras Dermatol. 2020 Mar-Apr; 95 (2): 187–193. https://doi.org/10.1016/j.abd.2019.08.023Aktaş Karabay E, Aksu Çerman A. Demodex folliculorum infestations in common facial dermatoses: Acne vulgaris, rosacea, seborrheic dermatitis. An Bras Dermatol. 2020 Mar-Apr; 95 (2): 187–193. https://doi.org/10.1016/j.abd.2019.08.023Foti C, Romita P, Borghi A, Angelini G, Bonamonte D, Corazza M. Contact dermatitis to topical acne drugs: A review of the literature. Dermatol Ther. 2015 Sep-Oct; 28 (5): 323–329. https://doi.org/10.1111/dth.12282Foti C, Romita P, Borghi A, Angelini G, Bonamonte D, Corazza M. Contact dermatitis to topical acne drugs: A review of the literature. Dermatol Ther. 2015 Sep-Oct; 28 (5): 323–329. https://doi.org/10.1111/dth.12282Veraldi S, Brena M, Barbareschi M. Allergic contact dermatitis caused by topical antiacne drugs. Expert Rev Clin Pharmacol. 2015; 8 (4): 377–381. https://doi.org/10.1586/17512433.2015.1046839Veraldi S, Brena M, Barbareschi M. Allergic contact dermatitis caused by topical antiacne drugs. Expert Rev Clin Pharmacol. 2015; 8 (4): 377–381. https://doi.org/10.1586/17512433.2015.1046839Церикидзе Н.Г., Сакания Л.Р., Корсунская И.М. Акне и розацеа: сходства и различия. Consilium Medicum. 2024; 26 (8): 530–534. https://doi.org/10.26442/20751753.2024.8.202957Tserikidze N.G., Sakaniya L.R., Korsunskaya I.M. Acne and rosacea: similarities and differences. Consilium Medicum. 2024; 26 (8): 530–534. https://doi.org/10.26442/20751753.2024.8.202957Portelinha ALZ, Ruppen IC, de Sousa RA, et al. Hormonal acne: Diagnosis and management. Medi Clin Case Rep J 2025; 3 (2): 876–878. https://doi.org/10.51219/MCCRJ/Ian-Caldeira-Ruppen/229Portelinha ALZ, Ruppen IC, de Sousa RA, et al. Hormonal acne: Diagnosis and management. Medi Clin Case Rep J 2025; 3 (2): 876–878. https://doi.org/10.51219/MCCRJ/Ian-Caldeira-Ruppen/229Bagatin E, Freitas THP, Rivitti-Machado MC, Machado MCR, Ribeiro BM, Nunes S, Rocha MADD. Adult female acne: A guide to clinical practice. An Bras Dermatol. 2019 JanFeb; 94 (1): 62–75. https://doi.org/10.1590/abd1806–4841.20198203. Erratum in: An Bras Dermatol. 2019 Mar-Apr; 94 (2): 255. https://doi.org/10.1590/abd1806–4841.2019940202Bagatin E, Freitas THP, Rivitti-Machado MC, Machado MCR, Ribeiro BM, Nunes S, Rocha MADD. Adult female acne: A guide to clinical practice. An Bras Dermatol. 2019 JanFeb; 94 (1): 62–75. https://doi.org/10.1590/abd1806–4841.20198203. Erratum in: An Bras Dermatol. 2019 Mar-Apr; 94 (2): 255. https://doi.org/10.1590/abd1806–4841.2019940202Ольховская К. Б. Характеристика гормонально-метаболических отклонений у женщин и мужчин с акне. Медицинский алфавит. 2025; (8): 69–73. https://doi.org/10.33667/2078-5631-2025-8-69-73Olkhovskaya K.B. Characteristics of hormonal and metabolic abnormalities in women and men with acne. Medical alphabet. 2025; (8): 69–73. (In Russ.). https://doi.org/10.33667/2078-5631-2025-8-69-73Sinikumpu SP, Jokelainen J, Tasanen K, Huilaja L. Cardiovascular and metabolic profile of subjects with acne in a cohort of middle-aged patients: A general population study of 1,932 subjects. Acta Derm Venereol. 2023 Jul 10; 103: adv5921. https://doi.org/10.2340/actadv.v103.5921Sinikumpu SP, Jokelainen J, Tasanen K, Huilaja L. Cardiovascular and metabolic profile of subjects with acne in a cohort of middle-aged patients: A general population study of 1,932 subjects. Acta Derm Venereol. 2023 Jul 10; 103: adv5921. https://doi.org/10.2340/actadv.v103.5921Fatima F, Das A, Kumar P, Datta D. Skin and metabolic syndrome: An evidence based comprehensive review. Indian J Dermatol. 2021 May-Jun; 66 (3): 302–307. https://doi.org/10.4103/ijd.IJD_728_20Fatima F, Das A, Kumar P, Datta D. Skin and metabolic syndrome: An evidence based comprehensive review. Indian J Dermatol. 2021 May-Jun; 66 (3): 302–307. https://doi.org/10.4103/ijd.IJD_728_20Carneiro ACA, de Carvalho JF, de Sá DC, Rodrigues CEM. Prevalence of metabolic syndrome and insulin resistance in adult patients with acne: Association with traditional cardiovascular risk factors and acne severity. Metab Syndr Relat Disord. 2023 Mar; 21 (2): 109–114. https://doi.org/10.1089/met.2022.0073Carneiro ACA, de Carvalho JF, de Sá DC, Rodrigues CEM. Prevalence of metabolic syndrome and insulin resistance in adult patients with acne: Association with traditional cardiovascular risk factors and acne severity. Metab Syndr Relat Disord. 2023 Mar; 21 (2): 109–114. https://doi.org/10.1089/met.2022.0073Chen YW, Wu CY, Chen YJ. Gastrointestinal comorbidities in patients with acne vulgaris: A population-based retrospective study. JAAD Int. 2024 Sep 27; 18: 62–68. https://doi.org/10.1016/j.jdin.2024.08.022.Chen YW, Wu CY, Chen YJ. Gastrointestinal comorbidities in patients with acne vulgaris: A population-based retrospective study. JAAD Int. 2024 Sep 27; 18: 62–68. https://doi.org/10.1016/j.jdin.2024.08.022.Thompson KG, Rainer BM, Antonescu C, et al. Minocycline and its impact on microbial dysbiosis in the skin and gastrointestinal tract of acne patients. Ann Dermatol. 2020 Feb; 32 (1): 21–30. https://doi.org/10.5021/ad.2020.32.1.21Thompson KG, Rainer BM, Antonescu C, et al. Minocycline and its impact on microbial dysbiosis in the skin and gastrointestinal tract of acne patients. Ann Dermatol. 2020 Feb; 32 (1): 21–30. https://doi.org/10.5021/ad.2020.32.1.21Монахов С.А., Богадельникова A.E. Инновационное решение в наружной терапии акне. Клиническая дерматология и венерология 2013; 11 (2): 36–40.Monakhov S. A., Bogadejnikova A. E. Innovative solution in external acne therapy. Clinical dermatology and venereology 2013; 11 (2): 36–40. (In Russ.).Волкова Н.В., Глазкова JI.K., Ретюнский К.Ю. Лечебно-диагностический алгоритм ведения больных акне с учетом коморбидных психических расстройств. Уральский медицинский журнал. 2013; 113 (8): 103–110.Volkova N.V., Glazkova J.I.K., Retyunsky K. Yu. Treatment and diagnostic algorithm for managing patients with acne, taking into account comorbid mental disorders. Ural medical journal. 2013; 113 (8): 103–110. (In Russ.).Kutlu Ö, Karadağ AS, Wollina U. Adult acne versus adolescent acne: a narrative review with a focus on epidemiology to treatment. An Bras Dermatol. 2023 Jan-Feb; 98 (1): 75–83. https://doi.org/10.1016/j.abd.2022.01.006Kutlu Ö, Karadağ AS, Wollina U. Adult acne versus adolescent acne: a narrative review with a focus on epidemiology to treatment. An Bras Dermatol. 2023 Jan-Feb; 98 (1): 75–83. https://doi.org/10.1016/j.abd.2022.01.006Nair PA, Saleh HM, Salazar FJ. Acneiform Eruptions. 2024 Jan 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.Nair PA, Saleh HM, Salazar FJ. Acneiform Eruptions. 2024 Jan 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.Yuan C, Wang B. Acneiform eruption induced by molecularly targeted agents in antineoplastic therapy: A review. J Cosmet Dermatol. 2023 Aug; 22 (8): 2150–2157. https://doi.org/10.1111/jocd.15704Yuan C, Wang B. Acneiform eruption induced by molecularly targeted agents in antineoplastic therapy: A review. J Cosmet Dermatol. 2023 Aug; 22 (8): 2150–2157. https://doi.org/10.1111/jocd.15704Okroglic L, Sohier P, Martin C, et al. Acneiform eruption following elexacaftor-tezacaftor-ivacaftor treatment in patients with cystic fibrosis. JAMA Dermatol. 2023 Jan 1; 159 (1): 68–72. https://doi.org/10.1001/jamadermatol.2022.5208Okroglic L, Sohier P, Martin C, et al. Acneiform eruption following elexacaftor-tezacaftor-ivacaftor treatment in patients with cystic fibrosis. JAMA Dermatol. 2023 Jan 1; 159 (1): 68–72. https://doi.org/10.1001/jamadermatol.2022.5208Elmas ÖF, Metin MS, Özyurt K, Atasoy M. Vitamin B12: An underestimated cause of acneiform drug eruption. Dermatol Ther. 2020 Jul; 33 (4): e13531. https://doi.org/10.1111/dth.13531Elmas ÖF, Metin MS, Özyurt K, Atasoy M. Vitamin B12: An underestimated cause of acneiform drug eruption. Dermatol Ther. 2020 Jul; 33 (4): e13531. https://doi.org/10.1111/dth.13531Bahbouhi I, Aboudourib M, Hocar O, Amal S. Vitamin B12 induced acneiform eruption. Heliyon. 2023 May 20; 9 (5): e16120. https://doi.org/10.1016/j.heliyon.2023.e16120Bahbouhi I, Aboudourib M, Hocar O, Amal S. Vitamin B12 induced acneiform eruption. Heliyon. 2023 May 20; 9 (5): e16120. https://doi.org/10.1016/j.heliyon.2023.e16120Кубанов А.А, Аравийская Е.А, Самцов А.В, Кондрахина И.Н, Махакова Ю.Б, Ласеев Д.И. Акне вульгарные: клинические рекомендации. М.; 2020. 33 с.Kubanov A.A., Araviyskaya E.A., Samtsov A.V., Kondrakhina I.N., Makhakova Yu.B., Laseev D.I. Acne vulgaris: clinical guidelines. Moscow; 2020. 33 p. (In Russ.).Bagatin E, Costa CS, Rocha MADD, et al. Consensus on the use of oral isotretinoin in dermatology – Brazilian Society of Dermatology. An Bras Dermatol. 2020 Nov-Dec; 95 Suppl 1 (Suppl 1): 19–38. https://doi.org/10.1016/j.abd.2020.09.001Bagatin E, Costa CS, Rocha MADD, et al. Consensus on the use of oral isotretinoin in dermatology – Brazilian Society of Dermatology. An Bras Dermatol. 2020 Nov-Dec; 95 Suppl 1 (Suppl 1): 19–38. https://doi.org/10.1016/j.abd.2020.09.001Feszak IJ, Brzeziński P, Feszak S, et al. Isotretinoin treatment for acne vulgaris: a five-year retrospective analysis of clinical and biochemical adverse effects. J Clin Med. 2025 Sep 14; 14 (18): 6473. https://doi.org/10.3390/jcm14186473Feszak IJ, Brzeziński P, Feszak S, et al. Isotretinoin treatment for acne vulgaris: a five-year retrospective analysis of clinical and biochemical adverse effects. J Clin Med. 2025 Sep 14; 14 (18): 6473. https://doi.org/10.3390/jcm14186473Zouboulis CC. Isotretinoin revisited: pluripotent effects on human sebaceous gland cells. J Invest Dermatol. 2006 Oct; 126 (10): 2154–2156. https://doi.org/10.1038/sj.jid.5700418Zouboulis CC. Isotretinoin revisited: pluripotent effects on human sebaceous gland cells. J Invest Dermatol. 2006 Oct; 126 (10): 2154–2156. https://doi.org/10.1038/sj.jid.5700418Karlsson T, Vahlquist A, Kedishvili N, Törmä H. 13-cis-retinoic acid competitively inhibits 3 alpha-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: a mechanism for its anti-androgenic effects in sebaceous glands? Biochem Biophys Res Commun. 2003 Mar 28; 303 (1): 273–278. https://doi.org/10.1016/s0006–291x(03)00332–2Karlsson T, Vahlquist A, Kedishvili N, Törmä H. 13-cis-retinoic acid competitively inhibits 3 alpha-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: a mechanism for its anti-androgenic effects in sebaceous glands? Biochem Biophys Res Commun. 2003 Mar 28; 303 (1): 273–278. https://doi.org/10.1016/s0006–291x(03)00332–2Chwalczuk M, Leszto K, Szweda F, et al. Multisystem adverse effects of isotretinoin: mechanistic insights and clinical implications. IJITSS. 2026; 1 (49). https://doi.org/10.31435/ijitss.1(49).2026.4579Chwalczuk M, Leszto K, Szweda F, et al. Multisystem adverse effects of isotretinoin: mechanistic insights and clinical implications. IJITSS. 2026; 1 (49). https://doi.org/10.31435/ijitss.1(49).2026.4579Негашева Е.С., Заторская Н.Ф., Валитова И.В., Рассадина З.В., Проскурина М.И., Блинова Д. А. Опыт применения системных ретиноидов в лечении акне у подростков с коморбидными кожными заболеваниями. Клиническая дерматология и венерология. 2020; 19 (4): 550–556. https://doi.org/10.17116/klinderma202019041550Negasheva E. S., Zatorskaya N. F., Valitova I. V., Rassadina Z. V., Proskurina M. I., Blinova D.A. Experience with the use of systemic retinoids in the treatment of acne in adolescents with comorbid skin diseases. Clinical dermatology and venereology. 2020; 19 (4): 550–556. (In Russ.). https://doi.org/10.17116/klinderma202019041550Перламутров Ю.Н., Ольховская К.Б. Приверженность пациентов к терапии акне с использованием системного изотретиноина. Клиническая дерматология и венерология. 2025; 24 (4): 461–466. https://doi.org/10.17116/klinderma202524041461Perlamutrov Yu.N., Olkhovskaya K.B. Patient adherence to acne therapy using systemic isotretinoin. Clinical dermatology and venereology. 2025; 24 (4): 461–466. (In Russ.). https://doi.org/10.17116/klinderma202524041461

The authors declare that there are no conflicts of interest present.